UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acute coronary syndromes in Europe: 1-year costs and outcomes

Current medical research and opinion, 2007-03, Vol.23 (3), p.495-503

2007

Volltextzugriff (PDF)

PCV97 AN EVALUATION OF ONCE- VERSUS TWICE-DAILY DOSING ON PERSISTENCE WITH PRESCRIPTION MEDICATIONS IN CARDIOVASCULAR PATIENTS

Value in health, 2010, Vol.13 (7), p.A359-A359

2010

Volltextzugriff (PDF)

PMC1 CLASSIFYING PATIENTS WITH METABOLIC SYNDROME USING THE LATENT CLASS ANALYSIS (LCA)

Value in health, 2009, Vol.12 (3), p.A19-A19

2009

Volltextzugriff (PDF)

PSY2 HOW WELL DOES BODY MASS INDEX PREDICT WAIST CIRCUMFERENCE FOR PATIENTS WITH METABOLIC SYNDROME?

Value in health, 2009, Vol.12 (3), p.A130-A130

2009

Volltextzugriff (PDF)

Predictors of high-cost managed care patients with acute coronary syndrome

Current medical research and opinion, 2005-12, Vol.21 (12), p.1977-1984

2005

Volltextzugriff (PDF)

PCV87 COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE

Value in health, 2009, Vol.12 (7), p.A328-A329

2009

Volltextzugriff (PDF)

PCV28 BALANCING EFFICACY AND SAFETY OF PRASUGREL VS. CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POPULATION ANALYSIS OF NET CLINICAL BENEFIT

Value in health, 2009, Vol.12 (7), p.A317-A317

2009

Volltextzugriff (PDF)

PCV43 PREDICTORS OF CLOPIDOGREL THERAPY PERSISTENCE IN ACUTE CORONARY SYNDROME PATIENTS

Value in health, 2007, Vol.10 (3), p.A49-A49

2007

Volltextzugriff (PDF)

Role of microtubules in contractile dysfunction of hypertrophied cardiocytes

Circulation (New York, N.Y.), 1994-07, Vol.90 (1), p.533-555

1994

Volltextzugriff (PDF)

PCV100 THE EFFECTS OF DOSING COMPLEXITY ON ADHERENCE WITH PRESCRIPTION MEDICATIONS COMMONLY USED FOR CARDIOVASCULAR PATIENTS

Value in health, 2010, Vol.13 (7), p.A360-A360

2010

Volltextzugriff (PDF)

PCV41 ADHERENCE TO GUIDELINES FOR SENSITIVITY ANALYSIS: COSTEFFECTIVENESS ANALYSES OF DUAL ORAL ANTIPLATELET THERAPY

Value in health, 2009, Vol.12 (3), p.A148-A148

2009

Volltextzugriff (PDF)

PCV157 MEDICATION ADHERENCE AND PERSISTENCE OF CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS WITH AND WITHOUT DIABETES MELLITUS

Value in health, 2009, Vol.12 (7), p.A343-A343

2009

Volltextzugriff (PDF)

PCV35 PRASUGREL AND CLOPIDOGREL PERSISTENCE AND DISCONTINUATION AMONG LOWER BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

Value in health, 2009, Vol.12 (7), p.A318-A318

2009

Volltextzugriff (PDF)

PCV107 CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES

Value in health, 2008, Vol.11 (6), p.A415-A415

2008

Volltextzugriff (PDF)

PCV60 BUDGET IMPACT MODEL FOR DETERMINING THE HOSPITAL COSTS OF INTRODUCING PRASUGREL FOR THE LONG TERM TREATMENT OF ACUTE CORONARY SYNDROME TREATED BY PERCUTANEOUS CORONARY INTERVENTION IN FRANCE

Value in health, 2009, Vol.12 (7), p.A323-A323

2009

Volltextzugriff (PDF)

PCV4 LONG-TERM THIENOPYRIDINE THERAPY IN ACS PATIENTS RESIDING IN THE UNITED KINGDOM

Value in health, 2005-05, Vol.8 (3), p.261-262

2005

Volltextzugriff (PDF)

PCV2 ACUTE CORONARY SYNDROMES: ONE YEAR COSTS AND OUTCOMES

Value in health, 2005-05, Vol.8 (3), p.261-261

2005

Volltextzugriff (PDF)

PCV33 ANALYSIS OF CLOPIDOGREL USE IN OUTPATIENT SETTINGS

Value in health, 2007, Vol.10 (3), p.A46-A47

2007

Volltextzugriff (PDF)

PCV2 CARDIOVASCULAR RISK FACTORS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES

Value in health, 2006-11, Vol.9 (6), p.A337-A337

2006

Volltextzugriff (PDF)

PCV68 CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN 5 EUROPEAN COUNTRIES

Value in health, 2006-11, Vol.9 (6), p.A358-A358

2006

Volltextzugriff (PDF)

PCV13 CLOPIDOGREL THERAPY AND HEALTH CARE COSTS FOLLOWING AN ACUTE CORONARY SYNDROME EVENT

Value in health, 2006-05, Vol.9 (3), p.A122-A122

2006

Volltextzugriff (PDF)

PCV19 ONE-YEAR COSTS FORACUTE CORONARY SYNDROME IN PATIENTS WITH AND WITHOUT REVASCULARIZATION DURING THE INITIAL HOSPITALIZATION

Value in health, 2006-05, Vol.9 (3), p.A124-A124

2006

Volltextzugriff (PDF)

PCV64 INDEX, FOLLOW-UP AND TOTAL HOSPITALIZATION COSTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PLANNED PERCUTANEOUS CORONARY INTERVENTION TREATED WITH PRASUGREL VS. CLOPIDOGREL IN THE TRITON-TIMI 38 TRIAL

Value in health, 2008, Vol.11 (6), p.A401-A401

2008

Volltextzugriff (PDF)

PCV86 COMPARISON OF PERSISTENCE AND ADHERENCE BETWEEN PRASUGREL AND CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTIONS

Value in health, 2008, Vol.11 (6), p.A408-A408

2008

Volltextzugriff (PDF)

PCV23 HEALTH CARE AND DRUG UTILIZATION PATTERNS IN PATIENTS RECEIVING LONG TERM THIENOPYRIDINE THERAPY

Value in health, 2004-05, Vol.7 (3), p.325-325

2004

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(19)
Internal Medicine
(16)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Pharmacology & Pharmacy
(12)
Female
(11)
Male
(11)
Middle Aged
(10)
Pharmacology. Drug Treatments
(10)
Aged
(9)
Cardiovascular System
(7)
Adult
(6)
Angioplasty, Balloon, Coronary - Economics
(5)
Antiarythmic Agents
(5)
Antibodies, Monoclonal - Economics
(5)
Cardiac & Cardiovascular Systems
(5)
Cardiovascular System & Cardiology
(5)
Immunoglobulin Fab Fragments - Economics
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute coronary syndromes in Europe: 1-year costs and outcomes

PCV97 AN EVALUATION OF ONCE- VERSUS TWICE-DAILY DOSING ON PERSISTENCE WITH PRESCRIPTION MEDICATIONS IN CARDIOVASCULAR PATIENTS

PMC1 CLASSIFYING PATIENTS WITH METABOLIC SYNDROME USING THE LATENT CLASS ANALYSIS (LCA)

PSY2 HOW WELL DOES BODY MASS INDEX PREDICT WAIST CIRCUMFERENCE FOR PATIENTS WITH METABOLIC SYNDROME?

Predictors of high-cost managed care patients with acute coronary syndrome

PCV87 COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE

PCV28 BALANCING EFFICACY AND SAFETY OF PRASUGREL VS. CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A POPULATION ANALYSIS OF NET CLINICAL BENEFIT

PCV43 PREDICTORS OF CLOPIDOGREL THERAPY PERSISTENCE IN ACUTE CORONARY SYNDROME PATIENTS

Role of microtubules in contractile dysfunction of hypertrophied cardiocytes

PCV100 THE EFFECTS OF DOSING COMPLEXITY ON ADHERENCE WITH PRESCRIPTION MEDICATIONS COMMONLY USED FOR CARDIOVASCULAR PATIENTS

PCV41 ADHERENCE TO GUIDELINES FOR SENSITIVITY ANALYSIS: COSTEFFECTIVENESS ANALYSES OF DUAL ORAL ANTIPLATELET THERAPY

PCV157 MEDICATION ADHERENCE AND PERSISTENCE OF CLOPIDOGREL IN ACUTE CORONARY SYNDROME PATIENTS WITH AND WITHOUT DIABETES MELLITUS

PCV35 PRASUGREL AND CLOPIDOGREL PERSISTENCE AND DISCONTINUATION AMONG LOWER BLEEDING RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

PCV107 CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES

PCV60 BUDGET IMPACT MODEL FOR DETERMINING THE HOSPITAL COSTS OF INTRODUCING PRASUGREL FOR THE LONG TERM TREATMENT OF ACUTE CORONARY SYNDROME TREATED BY PERCUTANEOUS CORONARY INTERVENTION IN FRANCE

PCV4 LONG-TERM THIENOPYRIDINE THERAPY IN ACS PATIENTS RESIDING IN THE UNITED KINGDOM

PCV2 ACUTE CORONARY SYNDROMES: ONE YEAR COSTS AND OUTCOMES

PCV33 ANALYSIS OF CLOPIDOGREL USE IN OUTPATIENT SETTINGS

PCV2 CARDIOVASCULAR RISK FACTORS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN FIVE EUROPEAN COUNTRIES

PCV68 CLOPIDOGREL PATTERNS OF USE IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN 5 EUROPEAN COUNTRIES

PCV13 CLOPIDOGREL THERAPY AND HEALTH CARE COSTS FOLLOWING AN ACUTE CORONARY SYNDROME EVENT

PCV19 ONE-YEAR COSTS FORACUTE CORONARY SYNDROME IN PATIENTS WITH AND WITHOUT REVASCULARIZATION DURING THE INITIAL HOSPITALIZATION

PCV64 INDEX, FOLLOW-UP AND TOTAL HOSPITALIZATION COSTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PLANNED PERCUTANEOUS CORONARY INTERVENTION TREATED WITH PRASUGREL VS. CLOPIDOGREL IN THE TRITON-TIMI 38 TRIAL

PCV86 COMPARISON OF PERSISTENCE AND ADHERENCE BETWEEN PRASUGREL AND CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND PERCUTANEOUS CORONARY INTERVENTIONS

PCV23 HEALTH CARE AND DRUG UTILIZATION PATTERNS IN PATIENTS RECEIVING LONG TERM THIENOPYRIDINE THERAPY

Suchergebnisse filtern